Wound healing kinetics of the genetically diabetic mouse

Wounds

Volumn 20, Issue 1, 2008, Pages 18-28

  Scherer, Sandra Saja ^a   Pietramaggiori, Giorgio ^a   Mathews, Jasmine C ^a   Chan, Rodney ^a   Fiorina, Paolo ^a   Orgill, Dennis P ^a  

^a NONE

Author keywords

Autolytic debridement; Compression stockings; Delayed wound healing; Diabetic foot wounds; Impaired wound healing; Mechanical debridement; Pressure dressing; Surgical debridement; Wound fibroblasts; Wound necrosis

Indexed keywords

EID: 38949180195     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. International Diabetes Federation. Available at: http:// www.idf.org/home/index.cfm. Accessed 2006.
2. Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrowderived cells. Am J Pathol. 2004;164(6):1935-1947.
3. Goulimari P, Kitzing TM, Knieling H, Brandt DT, Offermann S, Grosse R. Galphal2/13 is essential for directed cell migration and localized Rho-Dial function. J Biol Chem. 2005;280 (51):42242-42251.
4. Gottrup F, Agren MS, Karlsmark T. Models for use in wound healing research: a survey focusing on in vitro and in vivo adult soft tissue. Wound Repair Regen. 2000;8(2) :83-96.
5. Harrop AR, Ghahary A, Scott PG, Forsyth N, Uji-Friedland A, Tredget EE. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J Sum Res 1995-58(5):471-477.
6. MacDonald IM, Pannu R, Kovithavongs K, Peters C, Tredget EE, Ghahary A. Effect of retinoic acid on expression of transforming growth factorbeta by retinal pigment epithelial cells in culture. Can J Ophthalmol. 1995;30(6):301-305.
7. Woodley DT, Wynn KC, O'Keefe EJ. Type IV collagen and fibronectin enhance human keratinocyte thymidine incorporation and spreading in the absence of soluble growth factors. J Invest Dermatol. 1990;94(1):139-143.
8. Frank S, Stallmeyer B, Kämpfer H, KoIb N, Pfeilschifter J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. Faseb J. 1999; 13(14): 2002-2014.
9. Hager B, Bickenbach JR, Fleckman P. Long-term culture of murine epidermal keratinocytes. J Invest Dermatol. 1999; 112(6) :971-976.
10. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6 (4):389-395.
11. Abdollahi A, Hahnfeldt P, Maercker C, et al. Endostatin's antiangiogenic signaling network. Mol Cell. 2004; 13 (5):649-663.
12. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995;270(5241):1500-1502.
13. Bettinger D, Gore D, Humphries Y. Evaluation of calcium alginate for skin graft donor sites. J Burn Care Rehabil. 1995; 16(1): 59-61.
14. Calderon M, Lawrence WT, Banes AJ. Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res. 1996;61(2):343-347.
15. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA. 1979;76(3):1274-1278.
16. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994; 124(4) :401-404.
17. Morykwas MJ. In vitro properties of crosslinked, reconstituted collagen sheets. J Biomed Mater Res. 1990;24 (8):1105-1110.
18. Morykwas MJ, David LR, Schneider AM, et al. Use of subatmospheric pressure to prevent progression of partialthickness burns in a swine model. J Bum Care Rehabil. 1999;20(1 Pt 1):15-21.
19. Morykwas MJ, Kennedy A, Argenta JP, Argenta LC. Use of subatmospheric pressure to prevent doxorubicin extravasation ulcers in a swine model. J Surg Oncol. 1999;72 (1):14-17.
20. Buján J, Pascual G, Corrales C, Gomez-Gil V, Garcia-Honduvilla N, Bellon JM. Muscle-derived stem cells used to treat skin defects prevent wound contraction and expedite reepithelialization. Wound Repair Regen. 2006; 14(2):216-223.
21. Reid RR, Mogford JE, Butt R, deGiorgio-Miller A, Mustoe TA. Inhibition of procollagen C-proteinase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair Regen. 2006; 14(2): 138-141.
22. Lee JP, Jalili RB, Tredget EE, Demare JR, Ghahary A. Antifibrogenic effects of liposome-encapsulated IFNalpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res. 2005;25(10):627-631.
23. Said HK, Hijjawi J, Roy N, Mogford J, Mustoe T. Transdermal sustained-delivery oxygen improves epithelial healing in a rabbit ear wound model. Arch Surg. 2005; 140 (10):998-1004.
24. Lin MP, Marti GP, Dieb R, et al. Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair Regen. 2006; 14 (5):618-624.
25. Hata K, Fujitani M, Yasuda Y, et al. RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J Cell Biol. 2006; 173 (1):47-58.
26. Chan RK, Liu PH, Pietramaggiori G, Ibrahim SI, Hechtman HB, Orgill DP. Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice. J Burn Care Res. 2006;27(2):202-205.
27. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366 (9498):1736-1743.
28. Ferrara N. VEGF as a therapeutic target in cancer. Oncology. 2005;69(Suppl 3):11-16.
29. Greenhalgh DG. Models of wound healing. J Bum Care Rehabil. 2005;26(4):293-305.
30. Pietramaggiori A, Kaipainen A, Ho D, et al. Trehalose lyophilized platelets for wound healing. Wound Repair Regen. 2007;15(2):213-220.
31. Pietramaggiori G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP. Freeze-dried plateletrich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen. 2006;14(5):573-580.
32. Sullivan SR, Underwood RA, Gibran NS, et al. Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg. 2004;113(3):953-960.
33. Falanga V, Schrayer D, Cha J, et al. Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen. 2004; 12(3):320-326.
34. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev. 1970;22 (4):485-518.
35. Goodson WH 3rd, Hung TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res. 1977;22(3):221227.
36. Seifter E, Rettura G, Padawer J, Stratford F, Kambosos D, Levenson SM. Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin A. Ann Surg. 1981; 194 (1):42-50.
37. Cianfarani F, Zambruno G, Brogelli L, et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol. 2006; 169(4): 1167-1182.
38. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-432.
39. Goodson WH 3rd, Hunt TK. Wound collagen accumulation in obese hyperglycemic mice. Diabetes. 1986;35(4):491-495.
40. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/ db mice. Cell. 1996;84(3):491-495.
41. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes. 1982;31(Suppl 1 Pt 2):l-6.
42. Kaplan MM, Young JB. Abnormal thyroid hormone deiodination in tissues of ob/ob and db/db obese mice. Endocrinology. 1987; 120 (3):886-893.
43. Stallmeyer B, Kampfer H, Podda M, Kaufmann R, Pfeilschifter J, Frank S. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol. 2001;117(1):98-105.
44. Stallmeyer B, Pfeilschifter J, Frank S. Systemically and topically supplemented leptin fails to reconstitute a normal angiogenic response during skin repair in diabetic ob/ob mice. Diabetologia. 2001;44(4):471-479.
45. Man LX, Park JC, Terry MJ, et al. Lentiviral gene therapy with platelet-derived growth factor B sustains accelerated healing of diabetic wounds over time. Ann Plast Surg. 2005;55 (1):81-86.
46. Obara K, Ishihara M, Fujita M, et al. Acceleration of wound healing in healing-impaired db/ db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2. Wound Repair Regen. 2005;13(4):390-397.
47. Mulder G. Electroporatic delivery of TGF-betal gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol. 2004;123(4):xi.
48. Lee PY, Chesnoy S, Huang L. Electroporatic delivery of TGF-betal gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol. 2004; 123 (4):791-798.
49. Muangman P, Muffley LA, Anthony JP, et al. Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen. 2004; 12(1) :44-52.
50. Thenen SW, Mayer J. Adipose tissue glycerokinase activity in genetic and acquired obesity in rats and mice. Proc Soc Exp Biol Med. 1975; 148 (4):953-957.
51. Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes. 1996; 104(4): 293-300.
52. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension. 2003;41(3 Pt 2):763-767.
53. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology. 1996;47 (4): 1042-1048.
54. Pereira L, Matthes J, Schuster I, et al. Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes. 2006;55(3):608-615.
55. Greer JJ, Ware DP, Lefer DJ. Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol. 2006;290(1): H146-H153.
56. Carley AN, Semeniuk LM, Shimoni Y, et al. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab. 2004;286(3):E449- E455.
57. Garris DR. Variable onset determinants and consequences of diabetes (db/ db) obesity mutation expression: adrenergic promotion of utero-ovarian dysfunction. Horm Metab Res. 2004;36(5):312-318.
58. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269 (5223):546-549.
59. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543- 546.
60. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377 (6549):530-532.
61. Kieffer TJ, Heller RS, Leech CA, et al. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic betacells. Diabetes. 1997;46 (6):1087-1093.
62. Mikhail AA, Beck EX, Shafer A, et al. Leptin stimulates fetal and adult erythroid and myeloid development. Blood. 1997;89 (5):1507-1512.
63. Carlson MA, Longaker MT, Thompson JS. Wound splinting regulates granulation tissue survival. J Surg Res. 2003; 110 (1):304-309.
64. Reid RR, Said HK, Mogford JE, Mustoe TA. The future of wound healing: pursuing surgical models in transgenic and knockout mice. J Am Coll Surg. 2004; 199(4):578-585.
65. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol. 1990;136(6):1235-1246.
66. Yannas I. Tissue and Organ Regeneration in Adults. New York, NY: Springer; 2001.
67. Michaels JT, Dobryansky M, Galiano RD, et al. Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor demonstration. Wound Repair Regen. 2005;13(5):506-512.
68. Klingbeil CK, Cesar LB, Fiddes JC. Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. Prog Clin Biol Res. 1991;365:443-458.
69. Pietramaggiori G, Yang HJ, Scherer S, et al. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/ db mouse. J Trauma. In press.
70. Senter LH, Legrand EK, Laemmerhirt KE, Kiorpes TC. Assessment of full-thickness wounds in the genetically diabetic mouse for suitability as a wound healing model. Wound Repair Regen. 1995;3(3) :351-358.